TTNP
Titan Pharmaceuticals, Inc. (de)
Halal Rating :
Last Price
$3.81
Last updated:
Market Cap
-
7D Change
19.06%
1 Year Change
-41.83%
Company Overview
Industries
Exchange
Next Earnings Date
Titan Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of novel therapeutics using its proprietary long-term, continuous drug delivery platform, ProNeura™. The company's lead product candidate is a six-month implantable formulation of nalmefene for the prevention of opioid relapse.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Titan Pharmaceuticals, Inc. (de)'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.